TEVOGEN BIO HLDGS INC COM - Stock (LGST)

CUSIP: G8028L107

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Stock
Total 13F shares
26,751,208
Share change
+26,105,527
Total reported value
$267,209,000
Price per share
$9.99
Number of holders
62
Value change
+$260,759,013
Number of buys
61

Quarterly Holders Quick Answers

What is CUSIP G8028L107?
CUSIP G8028L107 identifies LGST - TEVOGEN BIO HLDGS INC COM - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TEVOGEN BIO HLDGS INC COM - Stock (LGST) as of Q1 2022

As of 31 Mar 2022, TEVOGEN BIO HLDGS INC COM - Stock (LGST) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,751,208 shares. The largest 10 holders included Saba Capital Management, L.P., Corbin Capital Partners, L.P., Polar Asset Management Partners Inc., Linden Advisors LP, MMCAP International Inc. SPC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, BANK OF MONTREAL /CAN/, Weiss Asset Management LP, Taconic Capital Advisors LP, and Periscope Capital Inc.. This page lists 62 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.